(Q422212)

budesonide (English)

3 October 2016

discoverer or inventor

Ralph Brattsand

1 reference

https://www.svt.se/nyheter/lokalt/skane/de-uppfann-medicin-mot-covid-for-50-ar-sedan

Arne Thalén

1 reference

https://www.svt.se/nyheter/lokalt/skane/de-uppfann-medicin-mot-covid-for-50-ar-sedan

chemical formula

C₂₅H₃₄O₆

1 reference

budesonide (English)

3 October 2016

CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C

1 reference

budesonide (English)

3 October 2016

CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@@]5([C@H]4[C@H](C[C@@]3([C@@]2(O1)C(=O)CO)C)O)C

1 reference

budesonide (English)

3 October 2016

9 milligram

oral administration

1 reference

https://www.whocc.no/atc_ddd_index/?code=A07EA06

0.2 milligram

nasal administration

1 reference

https://www.whocc.no/atc_ddd_index/?code=R01AD05

1 reference

14 February 2018

1 reference

14 February 2018

1 reference

14 February 2018

1 reference

14 February 2018

World Health Organisation international non-proprietary name

budesonide (English)

2 references

medical condition treated

budesonide (English)

3 October 2016

Recommended INN: List 17

publication date

1977

ulcerative colitis

1 reference

Drug Indications Extracted from FAERS

2 October 2018

microscopic colitis

1 reference

Drug Indications Extracted from FAERS

2 October 2018

colitis

1 reference

Drug Indications Extracted from FAERS

2 October 2018

14 January 2013

Food and Drug Administration

1 reference

Inxight: Drugs Database

2 November 2018

https://drugs.ncats.io/drug/Q3OKS62Q6X

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=230e4596-2a9b-4d55-b0a0-0cabbcff5289

asthma

start time

8 August 2000

approved by

Food and Drug Administration

1 reference

Inxight: Drugs Database

2 November 2018

https://drugs.ncats.io/drug/Q3OKS62Q6X

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=54234b7d-3bcc-4809-1881-1d21484856a0

Crohn's disease

start time

1 October 2001

approved by

Food and Drug Administration

1 reference

Inxight: Drugs Database

2 November 2018

https://drugs.ncats.io/drug/Q3OKS62Q6X

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=70532afa-4006-4883-feb2-927faaee8e20

significant drug interaction

nabumetone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

naproxen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

celecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Diclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

piroxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

meloxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(+-)-flurbiprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ibuprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indomethacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-etodolac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sulindac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

parecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aceclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenoxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

moxifloxacin

Achor-Smith syndrom

1 reference

established

A reference set of clinically relevant adverse drug-drug interactions

erythromycin

Achor-Smith syndrom

1 reference

probably

A reference set of clinically relevant adverse drug-drug interactions

clarithromycin

Achor-Smith syndrom

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nabumetone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

naproxen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

celecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Diclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

piroxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

meloxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(+-)-flurbiprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ibuprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indomethacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-etodolac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sulindac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

parecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aceclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenoxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ritonavir

Decreased circulating cortisol level

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ritonavir

Cushing's syndrome

1 reference

A reference set of clinically relevant adverse drug-drug interactions

moxifloxacin

tendon rupture

1 reference

established

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

Nuclear receptor subfamily 3 group C member 1

subject has role

agonist

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

7434

17 August 2016

legal status (medicine)

boxed warning

1 reference

https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802

imported from Wikimedia project

FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (English)

pregnancy category

US pregnancy category B

1 reference

English Wikipedia

subject has role

selective glucocorticoid receptor agonist

1 reference

5 March 2018

anti-inflammatory agent

1 reference

InChI=1S/C25H34O6/c1-4-5-21-30-20-11-17-16-7-6-14-10-15(27)8-9-23(14,2)22(16)18(28)12-24(17,3)25(20,31-21)19(29)13-26/h8-10,16-18,20-22,26,28H,4-7,11-13H2,1-3H3/t16-,17-,18-,20+,21?,22+,23-,24-,25+/m0/s1

Medical Subject Headings

15 March 2018

1 reference

Medical Subject Headings

15 March 2018

1 reference

Medical Subject Headings

15 March 2018

Budesonide

0 references

Identifiers

NL CR AUT ID

ph627209

subject named as

budesonid

0 references

InChI

1 reference

budesonide (English)

3 October 2016

2 references

budesonide (English)

3 October 2016

ChEBI release 2020-09-01

2 references

budesonide (English)

3 October 2016

https://commonchemistry.cas.org/detail?cas_rn=51333-22-3

8 April 2021

1 reference

Budesonide (English)

3 October 2016

2 references

budesonide (English)

3 October 2016

ChEBI ID

3207

mapping relation type

2 references

budesonide (English)

3 October 2016

International Chemical Identifier

InChI

InChI=1S/C25H34O6/c1-4-5-21-30-20-11-17-16-7-6-14-10-15(27)8-9-23(14,2)22(16)18(28)12-24(17,3)25(20,31-21)19(29)13-26/h8-10,16-18,20-22,26,28H,4-7,11-13H2,1-3H3/t16-,17-,18-,20+,21?,22+,23-,24-,25+/m0/s1

1 reference

BUDESONIDE (English)

3 October 2016

2 references

inferred from InChIKey

splash10-00dj-3950000000-8e98d604876730f53851

1 reference

MassBank accession ID

MSBNK-Waters-WA001151

0 references

MSBNK-Waters-WA001152

0 references

MSBNK-Waters-WA001153

0 references

MSBNK-Waters-WA001154

0 references

MSBNK-Waters-WA001155

0 references

MSBNK-Waters-WA001156

0 references

SPLASH

0 references

HSDB ID

8279

1 reference

Hazardous Substances Data Bank

28 October 2019

Budesonide (English)

10 May 2021

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

0 references

0 references

ECHA Substance Infocard ID

100.051.927

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

27 December 2018

Budesonide (English)

CAS no.: 51333-22-3 (English)

1 reference

Budesonide (English)

17 November 2015

1 reference

Budesonide (English)

17 November 2015

1 reference

Budesonide (English)

17 November 2015

1 reference

World Health Organisation international non-proprietary name numeric ID

Budesonide (English)

publication date

17 November 2015

4145

1 reference

https://mednet-communities.net/inn/db/ViewINN.aspx?i=4145

Guide to Pharmacology Ligand ID

7434

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

7434

D04.210.500.745.745.654.105

budesonide (English)

3 October 2016

Budesonide

0 references

MeSH tree code

0 references

0 references

1 reference

Human Metabolome Database ID

HMDB0015353

2 references

based on heuristic

inferred from InChIKey

2 references

Budesonide (English)

3 October 2016

MedlinePlus drug identifier

a608007

oral administration

0 references

a601030

nasal administration

0 references

a699056

inhalation administration

0 references

1 reference

BUDESONIDE (English)

19 January 2016

0 references

1 reference

1 reference